Caris Life Sciences
6655 North MacArthur Boulevard
Irving
Texas
75039
United States
Tel: 214-277-8700 or 800-979-8292
Fax: 214-596-7425
Website: http://www.carislifesciences.com/
219 articles with Caris Life Sciences
-
Caris Life Sciences and Elevation Oncology Announce Joint Discovery and Development Collaboration Focused on Oncogenic Fusions and Driver Mutations
6/15/2021
Caris Life Sciences® and Elevation Oncology announced a strategic collaboration to jointly identify oncogenic fusions and mutations that are driver alterations.
-
Shares of Fate climbed nearly 4% in premarket trading after it announced positive interim data from a Phase I study of FT516 for patients with relapsed / refractory B-cell lymphoma.
-
New Research from Caris Life Sciences Finds Immunotherapy Resistance in Leiomyosarcoma
6/4/2021
Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, to present findings that provide a deeper understanding of how immunotherapies affect leiomyosarcoma, a rare cancer that affects smooth muscle tissue, through the use of whole exome and whole transcriptome sequencing.
-
Caris Life Sciences and National Cancer Center Japan Announce Exclusive Collaboration to Launch The SCRUM-Japan MONSTAR-SCREEN-2 Trial
5/20/2021
Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced they have entered into an exclusive collaboration agreement with the National Cancer Center Japan to provide Caris' comprehensive molecular profiling in MONSTAR-SCREEN-2 of SCRUM-Japan, the largest cancer genomic screening consortium in Japan.
-
ASCO 2021 Showcases the Impact of Caris' Molecular Science Data in Advancing Cancer Care
5/18/2021
Over 20 studies to be presented at ASCO, featuring data from leading cancer research institutions across the U.S. in partnership with Caris Life Sciences, highlighting Caris' innovative technology and robust clinico-genomic database.
-
Sidney Kimmel Cancer Center at Jefferson Health Joins Caris Life Sciences' Precision Oncology Alliance
5/14/2021
National Cancer Institute-designated Sidney Kimmel Cancer Center partners with Caris' collaborative network of oncology experts to advance personalized cancer treatments
-
The company has raised approximately $1.3 billion in external financing over the past three years, including $310 million in 2020.
-
Caris Life Sciences Announces Appointment of Joseph E. Gilliam to Board of Directors
4/28/2021
Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced the appointment of Joseph E. Gilliam to the Caris Board of Directors, effective April 12, 2021.
-
Caris Life Sciences Launches HLA Genotype Reporting, the Newest Addition to its Suite of Comprehensive Molecular Science Offerings
3/24/2021
Caris HLA Genotype Reporting Provides Expanded Molecular Intelligence and Enhanced Ability to Provide More Individualized Treatment Decisions for Patients
-
Sutter Health Joins Caris' Precision Oncology Alliance to Advance Research and Personalized Treatments for Patients with Cancer
3/23/2021
Sutter's California Pacific Medical Center Cancer Center in San Francisco is the newest member of Caris' collaborative network of oncology institutions
-
Caris Life Sciences Study Provides First Systematic Assessment of RNA Expression of Key Molecules Involved in the Infectious Process Leading to COVID-19 in Advanced Cancer
3/16/2021
New Data Published in Scientific Reports Reveals Possible Biological Underpinnings of Cancer Patients Hyper-Immune Response to COVID-19 Infection
-
Caris' Precision Oncology Alliance Continues to Grow Internationally as it Welcomes Curie Oncology from Singapore
3/9/2021
Curie Oncology expands Caris' collaborative network of oncology institutions focused on research into personalized therapies through precision medicine
-
Moores Cancer Center at UC San Diego Health Joins Caris' Precision Oncology Alliance
3/2/2021
Moores Cancer Center unites cancer-related research laboratories, clinical trials, prevention and outreach programs, and patient care under one roof -- a design that encourages interaction and intellectual exchanges between world-renowned clinicians and researchers
-
Dana-Farber Cancer Institute, a Pioneer in Cancer Care and Research, Joins Caris' Precision Oncology Alliance
2/16/2021
Dana-Farber Cancer Institute is the latest member to join Caris' collaborative network of leading oncology institutions, focused on expanding the application of precision medicine in oncology
-
Caris Life Sciences to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference 2021
2/9/2021
Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence, focused on fulfilling the promise of precision medicine, announced today that David D. Halbert , Chairman and Chief Executive Officer, Brian J. Brille , Vice Chairman, David Spetzler , MS, MBA, Ph.D., President and Chief Scientific Officer will host a fireside chat at the BTIG Virtual MedTech Conference 2021
-
Caris Life Sciences Accurately Identifies 21 Cancer Types Using Artificial Intelligence Derived Molecular Signatures
1/19/2021
Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced positive results from a study using MI GPSai™ an artificial intelligence driven product using DNA sequencing and whole transcriptome data to aid in the diagnosis of cancer.
-
Caris Life Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
1/5/2021
Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced that the company will present at the 39th Annual J.P. Morgan Healthcare Conference, which is being held virtually, on January 12, 2021, at 12:10 p.m. ET.
-
Caris Life Sciences Publishes New Data in Clinical Cancer Research Demonstrating 71% Difference in Overall Survival for mCRC Patients Using Its AI-Based MI FOLFOXai Predictor
12/8/2020
Caris' AI-powered predictor helps gauge which metastatic colorectal cancer patients will benefit from treatment with current standard of care regimen Exploratory analyses also found benefit in advanced esophageal/gastro-esophageal junction cancers and pancreatic ductal adenocarcinoma
-
Caris Life Sciences Announces Huntsman Cancer Institute Joins its Precision Oncology Alliance
11/10/2020
Through its collaborative network focused on expanding the application of precision medicine in oncology, Caris will support Huntsman Cancer Institute's work to understand cancer from its beginnings and use that knowledge to improve cancer treatments
-
The life sciences industry is one of the fastest growing in the world. BioSpace provides a rundown of companies announcing facility and job expansions across the U.S. and beyond.